Apellis Pharmaceuticals Inc Haszonkulcs

Mi az Apellis Pharmaceuticals Inc Haszonkulcs?

A Haszonkulcs az Apellis Pharmaceuticals Inc - -133.29%

Mi a Haszonkulcs meghatározása?

A haszonkulcs a jövedelmezőség mértéke, és úgy kerül kiszámításra, hogy a nettó nyereséget a bevétel százalékában állapítja meg.

Profit margin is calculated with the selling price (or revenue) taken as base times 100. It is the percentage of selling price that is turned into profit. Profit percentages are calculated to find the ratio of profit to cost of an investment. Profit margin is an indicator of a company's pricing strategies and how well it controls costs. Differences in competitive strategy and product mix cause the profit margin to vary among different companies. The profit margin is used mostly for internal comparisons. It is difficult to accurately compare the net profit ratio for different entities. Individual businesses' operating and financing arrangements vary so much that different entities are bound to have different levels of expenditure, so that comparison of one with another can have little meaning. A low profit margin indicates a low margin of safety: higher risk that a decline in sales will erase profits and result in a net loss, or a negative margin.

Mit csinál Apellis Pharmaceuticals Inc?

apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.

haszonkulcs -hoz hasonló cégek Apellis Pharmaceuticals Inc